Latest News

US INVESTOR PRESENTATION 09-Feb-2010


BIONOMICS LIMITED BROADCAST 04-Feb-2010


POSITIVE NEW BNC210 DATA 02-Feb-2010


BNC105 US RENAL CANCER TRIAL INITIATED 27-Jan-2010


OPEN BRIEFING - BNC105 PHASE II TRIAL FOR MESOTHELIOMA 22-Dec-2009


APPOINTMENT OF CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY 18-Dec-2009


BNO NOW DECEMBER 09 NEWSLETTER 14-Dec-2009


BIONOMICS PARTNERS WITH THE AUSTRALASIAN LUNG CANCER TRIALS GROUP AND NHMRC CLINICAL TRIALS CENTRE TO CONDUCT BNC105 PHASE II TRIAL FOR MESOTHELIOMA T 09-Dec-2009


BIONOMICS 2009 AGM BROADCAST 06-Nov-2009


CHAIRMAN'S ADDRESS 04-Nov-2009


CEO'S ADDRESS 04-Nov-2009


NEW CHAIRMAN'S ADDRESS 04-Nov-2009


FIRST STAGE OF BNC210 CLINICAL TRIAL SUCCESSFULLY COMPLETED 27-Oct-2009


LATEST BNC210 DATA TO BE PRESENTED IN US 16-Oct-2009


SPP CLOSES OVERSUBSCRIBED 08-Oct-2009


INVITATION TO SHAREHOLDERS TO TOUR BIONOMICS FACILITY 08-Oct-2009


NOTICE OF ANNUAL GENERAL MEETING /PROXY FORM 02-Oct-2009


ANNUAL REPORT TO SHAREHOLDERS 2009 30-Sep-2009


BOARDROOM RADIO BROADCAST - BNO INVESTOR UPDATE SEPTEMBER 2009 18-Sep-2009


CEO OPEN BRIEFING 17-Sep-2009


2009 SHARE PURCHASE PLAN OFFER - ADDENDUM 17-Sep-2009


CAPITAL RAISING UPDATE - SHARE PURCHASE PLAN 11-Sep-2009


NOTICE OF EXTRAORDINARY GENERAL MEETING & PROXY FORM 10-Sep-2009


$15 MILLION CAPITAL RAISING 08-Sep-2009


INVESTOR UPDATE - SEPTEMBER 2009 08-Sep-2009


START-UP PLACEMENT 03-Sep-2009


APPENDIX 4E 28-Aug-2009


BNO JULY 2009 NEWSLETTER 27-Jul-2009


BIONOMICS TO UNDERTAKE US CLINICAL TRIAL OF BNC105 IN RENAL CELL CANCER 02-Jul-2009


OPEN BRIEFING - BNO CEO ON MILESTONES ACHIEVED 02-Jul-2009


BNO BROADCAST – HEALTHY INVESTMENT eCONFERENCE PRESENTATION 01-Jul-2009


PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI ANXIETY DRUG BNC210 INITIATED 25-Jun-2009


CANCER FIGHTING COMPOUND - BNC105 TO AIR ON ABC RADIO AUSTRALIA 15-Jun-2009


BOARDROOM RADIO BROADCAST - BNC210 APPROVED TO ENTER TRIAL 04-Jun-2009


INITIAL DATA FROM BNC105 PHASE I CLINICAL TRIAL PRESENTED 29-May-2009


OEN BRIEFING BNC105 INTERIM DATA 29-May-2009


BIONOMICS’ ANXIETY DRUG CANDIDATE APPROVED TO ENTER HUMAN CLINICAL TRIAL 21-May-2009


BNO - CEO PRESENTATION MAY 2009 05-May-2009


NEW BNC105 DATA PRESENTED AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE 22-Apr-2009


OPEN BRIEFING - NEW DATA ON BNC105 22-Apr-2009


BIONOMICS NAMED IN SMART 100 INDEX 15-Apr-2009


BIONOMICS APRIL 2009 NEWSLETTER 09-Apr-2009


BOARDROOM RADIO BROADCAST - HALF YEARLY REPORT 03-Mar-2009


KEY INSTITUTIONAL INVESTOR SUPPORTS BNO CAPITAL RAISING 10-Feb-2009


OPEN BRIEFING - CEO ON OPTION EXPIRY 05-Feb-2009


BNOOB OPTIONS EXERCISE 30-Jan-2009


INVESTOR PRESENTATION - JANUARY 2009 19-Jan-2009


OPEN BRIEFING - CEO UPDATE 15-Jan-2009


BIONOMICS NOW JANUARY NEWSLETTER 14-Jan-2009


BIONOMICS ANNOUNCES ADDITION TO BOARD 23-Dec-2008


BNOOB OPTIONS REMINDER 22-Dec-2008


BIONOMICS’ ANTI-ANXIETY CANDIDATE BNC210 SUCCESSFULLY COMPLETES SAFETY STUDIES 17-Dec-2008


OPTIONS UNDERWRITING 16-Dec-2008


OPEN BRIEFING - BNO CEO ON RECENT DEVELOPMENTS 12-Nov-2008


AGM BROADCAST 11-Nov-2008


AUSTIN HEALTH COMES ON BOARD BNC105 TRIAL 05-Nov-2008


BNC105 CLINICAL TRIAL UPDATE 16-Sep-2008


US AND EUROPEAN INVESTOR PRESENTATION 08-Sep-2008


BIONOMICS NOW SEPTEMBER NEWSLETTER 05-Sep-2008


BIONOMICS’ COMPOUND BNC210 DECREASES ANXIETY IN ANIMAL MODELS - LATEST DATA PRESENTED AT EUROPEAN CONFERENCE 01-Sep-2008


BIONOMICS' 2007/2008 PRELIMINARY FINAL RESULTS 22-Aug-2008


BIONOMICS EXTENDS CONTRACT OF CEO AND MANAGING DIRECTOR DEBORAH RATHJEN 08-Aug-2008


BNO AUDIO BROADCAST 17-Jul-2008


BIONOMICS COMPLETES GMP SYNTHESIS OF ANTI-ANXIETY DRUG BNC210 09-Jul-2008


BNO NEWSLETTER JULY 2008 30-Jun-2008


OPEN BRIEFING - BNO & MERCK SERONO DEVELOPMENT AGREEMENT 24-Jun-2008


MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT 19-Jun-2008


BNC105 NAMED AS ONE OF THE “TOP FIVE MOST PROMISING DRUGS ENTERING PHASE I TRIALS” IN THOMSON PHARMA THE ONES TO WATCH REVIEW 03-Jun-2008


BIONOMICS AWARDS GMP MANUFACTURE CONTRACT FOR ANXIETY DRUG CANDIDATE BNC210 16-Apr-2008


BIONOMICS PRESENTS BNC105 DATA AT INTERNATIONAL CANCER CONFERENCE 14-Apr-2008


BNO NEWSLETTER APRIL 2008 02-Apr-2008


BIONOMICS ADVANCES ANTI-ANXIETY CANDIDATE BNC210 11-Mar-2008


BIONOMICS STRENGTHENS BOARD WITH NEW APPOINTMENT 28-Feb-2008


CEO ON BNC105 PHASE I CLINICAL TRIALS 27-Feb-2008


TREATMENT OF FIRST PATIENT IN PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI-CANCER DRUG BNC105 26-Feb-2008


BIONOMICS ACHIEVES US$1 MILLION MILESTONE PAYMENT FROM GENMAB 19-Feb-2008


BIONOMICS NOW NEWSLETTER 21-Jan-2008


BIONOMICS’ ANTI-CANCER COMPOUND GAINS IND APPROVAL 22-Nov-2007


CHAIRMAN AND CEO ADDRESS 07-Nov-2007


BIONOMICS ACHIEVES KEY MILESTONES 07-Nov-2007


OPEN BRIEFING - CEO ON PIPELINE DEVELOPMENT STATUS 07-Nov-2007


AGM BROADCAST 07-Nov-2007


LATEST DATA PRESENTED AT INTERNATIONAL CONFERENCE 05-Oct-2007


NEWSLETTER TO SHAREHOLDERS 14-Sep-2007


2006 / 2007 FINANCIAL RESULTS – VARIATION TO 4E 07-Sep-2007


BIONOMICS' 2006/2007 PRELIMINARY FINAL RESULTS 29-Aug-2007


BIONOMICS TO DEVELOP CANCER DRUG TARGET BNO69 WITH SUPPORT FROM THE CANCER THERAPEUTICS CRC 06-Aug-2007


IBRO 2007 CONFERENCE POSTER - BNC210 13-Jul-2007


IBRO 2007 CONFERENCE POSTER - Kv1.3 ION CHANNEL BLOCKERS 13-Jul-2007


BIONOMICS PRESENTS MULTIPLE SCLEROSIS AND ANXIETY DRUG DATA AT INTERNATIONAL CONFERENCE 13-Jul-2007


S708A PLACEMENT NOTICE 05-Jul-2007


BNOOA OPTION EXPIRY NOTICE 03-Jul-2007


AUDIO BROADCAST - BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 21-Jun-2007


BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 20-Jun-2007


BIONOMICS NEWSLETTER - JUNE 2007 12-Jun-2007


BIONOMICS’ VALIDATES THIRD CANCER APPLICATION FOR ANTI-CANCER COMPOUND BNC105 04-Jun-2007


OPEN BRIEFING - BIONOMICS PIPELINE UPDATE 04-Jun-2007


AUDIO BROADCAST - BIONOMICS MD - NEW DRUG CANDIDATE FOR ANXIETY 31-May-2007


BIONOMICS VALIDATES DRUG CANDIDATE FOR ANXIETY 29-May-2007


BIONOMICS COMPLETES GMP SYNTHESIS OF CANCER DRUG BNC105 ON TIME AND ON BUDGET 23-Apr-2007


OPEN BRIEFING - UPDATE ON BNC105 MILESTONES 23-Apr-2007


US$890 MILLION VDA DEAL INDICATES VALUE OF BIONOMICS’ BNC105 CANCER COMPOUND 23-Apr-2007


BIONOMICS ESTABLISHES NEW LABORATORY FACILITY TO ACCELERATE LATER STAGE DRUG DEVELOPMENT 19-Apr-2007


BIONOMICS PRESENTS CANCER DATA AT AACR CONFERENCE 17-Apr-2007


AACR Poster 17-Apr-2007


INVESTOR BRIEFING - EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007


M & A PRESENTATION – EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007


BIONOMICS SHAREHOLDER NEWSLETTER – MARCH 2007 13-Mar-2007


BIONOMICS TAKES KEY STEP FORWARD IN THE DEVELOPMENT OF ANTI-CANCER DRUG BNC105 21-Feb-2007


BIONOMICS MEETS WITH FDA IN US 17-Jan-2007


BIONOMICS TO BENEFIT FROM AU$37.60M FEDERAL CRC GRANT FOR CANCER DRUG DEVELOPMENT 02-Jan-2007


BIONOMICS NEWSLETTER 04-Dec-2006


BIONOMICS MD UPDATES OUTLOOK 16-Nov-2006


BIONOMICS DELIVERS ON MILESTONES FOR DRUG DISCOVERY PROGRAMS 09-Nov-2006


AGM CHAIRMAN AND CEO ADDRESSES 2006 09-Nov-2006


BNO AUDIO BROADCAST 09-Nov-2006


BNO AUDIO BROADCAST 25-Oct-2006


BIONOMICS AND SAFC PHARMA SIGN CONTRACT TO MANUFACTURE BNC105 25-Oct-2006


ASIA PACIFIC LIFE SCIENCES FORUM - PRESENTATION 12-Oct-2006


BIONOMICS TO CONDUCT BNC105 PHASE II TRIAL FOR MESOTHELIOMA TREATMENT 09-Feb-2010


curve
Website design and development by Plastyk Studios